The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 1.00 (0.96%)
Spread: 6.00 (5.882%)
Open: 104.00
High: 105.00
Low: 104.00
Prev. Close: 104.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major New Contract Win

3 Jan 2024 07:00

RNS Number : 4396Y
Intercede Group PLC
03 January 2024
 

03 January 2024

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Major New Contract Win

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce that the Group has been awarded a major licence order with associated support and maintenance totalling approximately $1.0 million for a new client in the US Intelligence Community. In addition to the perpetual licence order, the client is also contracted for a separate annual subscription of $0.2 million.

 

This order, combined with expected additional conversion of our existing pipeline in Q4, means that the Company now expects financial performance to be ahead of market expectations for FY24* and further underpins FY25.

 

Klaas van der Leest, CEO, commented:

 

"We are particularly pleased to secure this order because it has potential to grow further and the fact that there is a subscription element associated with it.

 

The order was contracted through the channel, again underpinning our go-to-market strategy. We have ended 2023 on a high and aim to continue with this momentum into the final quarter and FY25".

 

* The current market forecast for the year ending 31 March 2024 is revenue of £18 million and adjusted EBITDA of £5.2 million.

 

 

ENQUIRIES

Intercede Group plc Tel. +44 (0)1455 558 111

Klaas van der Leest, CEO

Nitil Patel, CFO

 

Cavendish Capital Markets Limited Tel. +44 (0)20 7220 0500

Simon Hicks/Fergus Sullivan, Corporate Finance

Tim Redfern, ECM

 

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and custom development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

For more information visit: www.intercede.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTSSUFUEELSEFF
Date   Source Headline
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement
26th Jan 200610:38 amRNSFurther re OEM Agreement
20th Dec 200511:29 amRNSDirector/PDMR Shareholding
15th Dec 20057:00 amRNSInterim Results
12th Dec 200512:28 pmRNSRe New OEM Agreement
9th Dec 200512:47 pmRNSHolding(s) in Company
30th Nov 200510:42 amRNSFurther re OEM Agreement
21st Nov 20051:44 pmRNSFurther re Global OEM Licence
12th Sep 20057:00 amRNSRe: Global OEM Licence
13th Jun 20054:12 pmRNSHolding(s) in Company-Amend
25th May 200512:04 pmRNSHolding(s) in Company
24th May 20057:00 amRNSFinal Results
31st Mar 20057:00 amRNSTrading Statement
24th Feb 200512:48 pmRNSRe Contract
21st Jan 20059:11 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.